These approaches range from pharmacological options such as tissue plasminogen activator (tPA), which dissolves clots [12], to other medications, such as ACE inhibitors, calcium channel blockers, and beta-blockers, which help manage hypertension and decrease the heart’s need for oxygen. This evidence concerns the gene PLAT and hypertensive disorder.